ULBP2/aCD19/aCD19 efficiently binds to all target moieties simultaneously by retargeting NK cells to kill tumor cells in an antigen-specific manner and mediates efficient NK cell-dependent killing of primary CLL cells both in allogenic and autologous settings. Here, ULBP2 is linked to B-cell chronic lymphocytic leukemia.